Approvals in 2022: overall survival, dose optimization, new approvals and beyond

被引：2
|
作者：
Telaraja, Deepti [1 ]
Gormley, Nicole [1 ]
Pazdur, Richard [2 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
[2] US FDA, Oncol Ctr Excellence, Silver Spring, MD USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2023年 / 20卷 / 04期
关键词：
INHIBITORS;
D O I：
10.1038/s41571-023-00741-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In 2022, the FDA approved numerous new drug and biologic agents, including targeted small molecules, immunotherapeutics, a gene therapy and a radiopharmaceutical. Several drug development challenges were also addressed, and key focus areas for the FDA Oncology Center of Excellence included ongoing monitoring of the Accelerated Approval programme and drug dose optimization.
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [1] Approvals in 2022: overall survival, dose optimization, new approvals and beyond
    Deepti Telaraja
    Nicole Gormley
    Richard Pazdur
    [J]. Nature Reviews Clinical Oncology, 2023, 20 : 207 - 208
  • [2] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Lemery, Steven
    Pazdur, Richard
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 217 - 218
  • [3] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Steven Lemery
    Richard Pazdur
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 217 - 218
  • [4] 2022 FDA approvals
    Mullard, Asher
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (02) : 83 - 88
  • [5] 2022 FDA approvals
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 83 - 88
  • [6] 2022 in review: FDA approvals of new medicines
    Kinch, Michael S.
    Kraft, Zachary
    Schwartz, Tyler
    [J]. DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [7] New Approvals
    Kaufman, Michele B.
    [J]. DIALYSIS & TRANSPLANTATION, 2011, 40 (02) : 89 - 90
  • [8] New Approvals
    Kaufman, Michele B.
    [J]. DIALYSIS & TRANSPLANTATION, 2011, 40 (06) : 272 - 273
  • [9] New Approvals
    Kaufman, Michele B.
    [J]. DIALYSIS & TRANSPLANTATION, 2011, 40 (09) : 422 - 423
  • [10] FDA Approvals of Biologics in 2022
    Martins, Alexander C.
    Albericio, Fernando
    de la Torre, Beatriz G.
    [J]. BIOMEDICINES, 2023, 11 (05)
12345